
Impact of HCV ns5a resistance associated substitutions on treatment outcome of chronic HCV in daclatasvir-based antiviral regimens
Author(s) -
Gamal Esmat,
Abdel-Rahman N. Zekri,
Mohammad Elsayed,
Hany K Soliman,
Eman Medhat,
Mohamed Abo El Kassem Abo Daif
Publication year - 2022
Publication title -
international journal of health sciences (ijhs) (en línea)
Language(s) - English
Resource type - Journals
eISSN - 2550-6978
pISSN - 2550-696X
DOI - 10.53730/ijhs.v6ns7.11489
Subject(s) - ns5a , daclatasvir , medicine , cohort , gastroenterology , hepatitis c virus , virology , virus , ribavirin , hepacivirus